Most of our knowledge about the pathogenic factors involved in DCM has been provided by studies performed in a variety of rodent models of type 1 and type 2 diabetes or genetically engineered mouse models that lack important molecular components of the insulin signaling pathway. This evidence concerns the gene INS and familial dilated cardiomyopathy.